Related Experiment Video
Updated: May 22, 2026

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
Published on: February 10, 2023
Thrombophilia in venous leg ulcers: a comparative study in early and later onset
Ana M Calistru1, Teresa Baudrier, Luciana Gonçalves
1Department of Dermatology and Venereology, Hospital São João, EPE, Porto, Portugal. anagruia@yahoo.com
Insights
Patients with early-onset chronic venous ulcers (CVU) exhibit a significantly higher thrombophilic risk, indicated by multiple thrombophilias. Early screening for thrombophilia in CVU patients under 50 is crucial for risk stratification and management.
Area of Science:
- Vascular Medicine
- Hematology
- Genetics
Background:
- Chronic venous ulcers (CVU) are associated with a high prevalence of thrombophilia, similar to deep vein thrombosis (DVT).
- Patients developing CVU before age 50 represent a distinct clinical group regarding etiology, progression, and outcomes.
Purpose of the Study:
- To compare thrombophilia prevalence and nature in early-onset CVU (before 50) versus late-onset CVU.
- To identify specific thrombophilic factors associated with early-onset CVU.
Main Methods:
- Clinical assessment and blood tests for thrombophilia markers in 27 early-onset and 27 late-onset CVU patients.
- Testing included factor V Leiden, prothrombin G20210A, PAI-1 mutations, protein levels, and antiphospholipid antibodies.
Main Results:
- All patients presented at least one thrombophilia. Early-onset CVU showed a significantly higher prevalence of multiple (≥3) thrombophilias (29.6% vs 7.4%) and homozygous mutations (P=0.03).
- The PAI-1 4G/4G mutation was more common in early-onset cases. Higher, though not statistically significant, rates of Factor V Leiden, prothrombin G20210A, and antiphospholipid antibodies were observed in the early-onset group.
Conclusions:
- Early-onset CVU is linked to a significantly elevated thrombophilic risk, characterized by multiple thrombophilias and homozygous mutations.
- Thrombophilia screening in CVU patients under 50 is vital for risk stratification and guiding prophylactic and therapeutic strategies.
Background:
Several studies found that the patients with chronic venous ulcers (CVU) have an increased prevalence of thrombophilia (44-75%), similar to that observed in deep vein thrombosis (DVT). The patients who develop CVU before their 50 th birthday appear to represent a distinct group in terms of etiology, natural history and prognosis.
Aim:
To analyze the nature and prevalence of thrombophilia in patients with early onset of CVU (before 50-years old) compared with a group of patients with later onset.
Methods:
Twenty-seven consecutive patients of each group were studied. They underwent clinical assessment and blood testing for factor V Leiden, prothrombin G20210A, methyltetrahydrofolate reductase C677T, plasminogen activator inhibitor type 1 (PAI-1) mutations, antithrombin, proteins C and S levels, and also antiphospholipid antibodies (anticardiolipin antibodies and lupus anticoagulant), cryoglobulins and cryoagglutinins.
Results:
All the patients had at least one thrombophilia. The prevalences of single, 2 and ≥3 thrombophilias were 29.6%, 40.7% and 29.6%, respectively, in the early onset group, compared with 33.3%, 59.2% and 7.4% in the later onset group. The PAI-1 4G/4G homozygous mutation was significantly more common in patients with early onset of ulcer. The prevalences of factor V Leiden, prothrombin G20210A, elevated titer of antiphospholipid antibodies and the presence of cryoglobulins were higher in the early onset group, although the differences were not statistically significant.
Conclusion:
Our study brings evidence of a higher thrombophilic risk among the patients with early onset of the CVU as they had significantly higher prevalence of multiple (≥3) thrombophilias (P=0.03), homozygous mutations (P=0.03) and family history of leg ulcer (P=0.02) when compared with patients with later onset. Thrombophilia screening is important in patients with CVU before the age of 50 in order to stratify the thrombotic risk and to allow an appropriate prophylactic and therapeutic management.
Related Concept Videos
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Varicose Veins I: Introduction
